• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP

CYNATA THERAPEUTICS LIMITED - Discussion

2.63% ! 19.5¢
Market Cap $46.30M  !
Healthcare Biotechnology
Add to My Watchlist

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Cynata Therapeutics Limited

edit-2 Created with Sketch. New Thread
refresh Created with Sketch. REFRESH
Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Pledge 119 32K 0 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 0
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Pledge 119 32K 0 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 0
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Pledge 119 32K 1 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 1 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Bazsa 119 32K 1 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 4 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 4
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Bazsa 119 32K 4 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 4
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 1 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Pledge 119 32K 1 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Pledge 119 32K 0 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 0
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Bazsa 119 32K 3 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 3
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Bazsa 119 32K 1 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 6 02/03/22
02/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 6
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Bazsa 119 32K 2 01/03/22
01/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 2
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Barman76 119 32K 0 01/03/22
01/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 0
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 1 01/03/22
01/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Barman76 119 32K 0 01/03/22
01/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 0
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Bunn-Wackett 119 32K 3 01/03/22
01/03/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 3
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 2 28/02/22
28/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 2
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Barman76 119 32K 1 28/02/22
28/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Wasabibarako 119 32K 3 28/02/22
28/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 3
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 3 28/02/22
28/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 3
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Barman76 119 32K 2 28/02/22
28/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 2
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Barman76 119 32K 0 28/02/22
28/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 0
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Rossi70 119 32K 6 28/02/22
28/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 6
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread JB1975 119 32K 1 28/02/22
28/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Bazsa 119 32K 2 28/02/22
28/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 2
ASX - By Stock CYP Ann: Notice of Allowance for Cynata Chinese Patent Thread ASX News 0 625 17 28/02/22
28/02/22 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 625 Likes Created with Sketch. 17
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 5 27/02/22
27/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 5
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Bazsa 119 32K 1 27/02/22
27/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 4 27/02/22
27/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 4
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Bunn-Wackett 119 32K 0 27/02/22
27/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 0
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Barman76 119 32K 1 27/02/22
27/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 4 26/02/22
26/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 4
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 4 26/02/22
26/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 4
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Bazsa 119 32K 1 26/02/22
26/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 5 26/02/22
26/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 5
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Bazsa 119 32K 0 26/02/22
26/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 0
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 5 26/02/22
26/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 5
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Bazsa 119 32K 0 26/02/22
26/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 0
ASX - By Stock CYP News: CYP Cynata Therapeutics Posts HY Loss Attributable Of A$1.1 Million Thread Hot News 0 304 1 25/02/22
25/02/22 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 304 Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Appendix 4D & Half-Year Financial Statements Thread Sector 6 1.8K 12 25/02/22
25/02/22 ASX - By Stock Thread Comments Created with Sketch. 6 Views Created with Sketch. 1.8K Likes Created with Sketch. 12
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 2 25/02/22
25/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Ann: Appendix 4D & Half-Year Financial Statements Thread ralom 6 1.8K 0 25/02/22
25/02/22 ASX - By Stock Thread Comments Created with Sketch. 6 Views Created with Sketch. 1.8K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Appendix 4D & Half-Year Financial Statements Thread truss20 6 1.8K 6 25/02/22
25/02/22 ASX - By Stock Thread Comments Created with Sketch. 6 Views Created with Sketch. 1.8K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Ann: Appendix 4D & Half-Year Financial Statements Thread ralom 6 1.8K 0 25/02/22
25/02/22 ASX - By Stock Thread Comments Created with Sketch. 6 Views Created with Sketch. 1.8K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Appendix 4D & Half-Year Financial Statements Thread truss20 6 1.8K 7 25/02/22
25/02/22 ASX - By Stock Thread Comments Created with Sketch. 6 Views Created with Sketch. 1.8K Likes Created with Sketch. 7
ASX - By Stock CYP Re: Ann: Appendix 4D & Half-Year Financial Statements Thread ralom 6 1.8K 3 25/02/22
25/02/22 ASX - By Stock Thread Comments Created with Sketch. 6 Views Created with Sketch. 1.8K Likes Created with Sketch. 3
ASX - By Stock CYP Ann: Appendix 4D & Half-Year Financial Statements Thread ASX News 6 1.8K 1 25/02/22
25/02/22 ASX - By Stock Thread Comments Created with Sketch. 6 Views Created with Sketch. 1.8K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Barman76 119 32K 2 24/02/22
24/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 2
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 1 24/02/22
24/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Barman76 119 32K 1 24/02/22
24/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 1
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 5 23/02/22
23/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 5
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread Sector 119 32K 5 23/02/22
23/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 5
ASX - By Stock CYP Re: GvHD - Orphan Drug - same drug - clinically superior - issues for CYP and MSB Thread pfeifer1982 119 32K 24 23/02/22
23/02/22 ASX - By Stock Thread Comments Created with Sketch. 119 Views Created with Sketch. 32K Likes Created with Sketch. 24
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Wasabibarako 109 25K 0 22/02/22
22/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Pledge 109 25K 0 22/02/22
22/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Bunn-Wackett 109 25K 0 22/02/22
22/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread JB1975 109 25K 1 22/02/22
22/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Pledge 109 25K 0 22/02/22
22/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread JB1975 109 25K 0 22/02/22
22/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Pledge 109 25K 0 22/02/22
22/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread JB1975 109 25K 2 22/02/22
22/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Pledge 109 25K 2 22/02/22
22/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Sector 109 25K 4 22/02/22
22/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Sector 109 25K 5 22/02/22
22/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Pledge 109 25K 0 22/02/22
22/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 0
Charts CYP Re: CYP chart Thread slick 1.9K 632K 0 22/02/22
22/02/22 Charts Thread Comments Created with Sketch. 1.9K Views Created with Sketch. 632K Likes Created with Sketch. 0
Charts CYP Re: CYP chart Thread Sector 1.9K 632K 0 22/02/22
22/02/22 Charts Thread Comments Created with Sketch. 1.9K Views Created with Sketch. 632K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread JB1975 109 25K 3 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 3
Charts CYP Re: CYP chart Thread slick 1.9K 632K 4 21/02/22
21/02/22 Charts Thread Comments Created with Sketch. 1.9K Views Created with Sketch. 632K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Bunn-Wackett 109 25K 0 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 0
Charts CYP Re: CYP chart Thread Sector 1.9K 632K 2 21/02/22
21/02/22 Charts Thread Comments Created with Sketch. 1.9K Views Created with Sketch. 632K Likes Created with Sketch. 2
Charts CYP Re: CYP chart Thread Wasabibarako 1.9K 632K 0 21/02/22
21/02/22 Charts Thread Comments Created with Sketch. 1.9K Views Created with Sketch. 632K Likes Created with Sketch. 0
Charts CYP Re: CYP chart Thread slick 1.9K 632K 13 21/02/22
21/02/22 Charts Thread Comments Created with Sketch. 1.9K Views Created with Sketch. 632K Likes Created with Sketch. 13
Charts CYP Re: CYP chart Thread Sector 1.9K 632K 0 21/02/22
21/02/22 Charts Thread Comments Created with Sketch. 1.9K Views Created with Sketch. 632K Likes Created with Sketch. 0
Charts CYP Re: CYP chart Thread Wasabibarako 1.9K 632K 1 21/02/22
21/02/22 Charts Thread Comments Created with Sketch. 1.9K Views Created with Sketch. 632K Likes Created with Sketch. 1
Charts CYP Re: CYP chart Thread slick 1.9K 632K 3 21/02/22
21/02/22 Charts Thread Comments Created with Sketch. 1.9K Views Created with Sketch. 632K Likes Created with Sketch. 3
Charts CYP Re: CYP chart Thread Wasabibarako 1.9K 632K 1 21/02/22
21/02/22 Charts Thread Comments Created with Sketch. 1.9K Views Created with Sketch. 632K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread JB1975 109 25K 3 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread whaleshark 109 25K 2 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Pledge 109 25K 2 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Pledge 109 25K 2 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread whaleshark 109 25K 10 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 10
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread JB1975 109 25K 8 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 8
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Pledge 109 25K 0 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread JB1975 109 25K 5 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Pledge 109 25K 0 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Bunn-Wackett 109 25K 0 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Sector 109 25K 1 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread JB1975 109 25K 5 21/02/22
21/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread Barman76 109 25K 0 19/02/22
19/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Phase 3 Osteoarthritis Clinical Trial Commences Thread Barman76 394 99K 2 19/02/22
19/02/22 ASX - By Stock Thread Comments Created with Sketch. 394 Views Created with Sketch. 99K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Ann: Annual Report to shareholders Thread ralom 109 25K 1 19/02/22
19/02/22 ASX - By Stock Thread Comments Created with Sketch. 109 Views Created with Sketch. 25K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Phase 3 Osteoarthritis Clinical Trial Commences Thread Pledge 394 99K 1 19/02/22
19/02/22 ASX - By Stock Thread Comments Created with Sketch. 394 Views Created with Sketch. 99K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Phase 3 Osteoarthritis Clinical Trial Commences Thread Barman76 394 99K 0 19/02/22
19/02/22 ASX - By Stock Thread Comments Created with Sketch. 394 Views Created with Sketch. 99K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: Phase 3 Osteoarthritis Clinical Trial Commences Thread Pledge 394 99K 1 19/02/22
19/02/22 ASX - By Stock Thread Comments Created with Sketch. 394 Views Created with Sketch. 99K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Phase 3 Osteoarthritis Clinical Trial Commences Thread Barman76 394 99K 1 19/02/22
19/02/22 ASX - By Stock Thread Comments Created with Sketch. 394 Views Created with Sketch. 99K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Phase 3 Osteoarthritis Clinical Trial Commences Thread Barman76 394 99K 1 19/02/22
19/02/22 ASX - By Stock Thread Comments Created with Sketch. 394 Views Created with Sketch. 99K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Phase 3 Osteoarthritis Clinical Trial Commences Thread Pledge 394 99K 2 19/02/22
19/02/22 ASX - By Stock Thread Comments Created with Sketch. 394 Views Created with Sketch. 99K Likes Created with Sketch. 2
refresh Created with Sketch. REFRESH

Featured News

NEWS The biggest ASX director trades from the last week
right-arrow Created with Sketch.
NEWS High-grade silver intercepts confirmed at Kempfield Project
right-arrow Created with Sketch.
NEWS Southern Silver Exploration: Unlocking value at Cerro Las Minitas amid rising metal prices
right-arrow Created with Sketch.
NEWS Explore the latest ASX Market News
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 025 – Locksley rap video gives Hilltop Hoods run for money
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
19.5¢ 		Change
0.005(2.63%) 		Mkt cap ! $46.30M
Open High Low Value Volume
19.0¢ 19.5¢ 19.0¢ $30.89K 162.5K

Buyers (Bids)

No. Vol. Price($)
1 29641 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 111465 1
View Market Depth
Last trade - 16.10pm 19/09/2025 (20 minute delay) ?
CYP (ASX) Chart

Top Stories

Market shows partial interest in Noviqtech as company flags launch of 'quantum' chatbot

NoviqTech shares were +16% higher late arvo as the company declared the successful launch of its "Quantum Intelligence" business.
HotCopper Highlights: Stakk's out-of-nowhere Robinhood deal; ADNOC dumps Santos after first date & more Greetings and welcome to HotCopper Highlights, I’m Jon Davidson, in this end of week wrap we look at the stocks you were watching and discussing the most this week, and let’s kick off looking at the most viewed. Banking software player Stakk attracted a lot of eyes...
Perseus off to races at Côte d'Ivoire gold mine after 'milestone' presidential decree Perseus Mining has landed formal approval from the President of the Republic of Côte d'Ivoire to start development and mining at Yaouré.
Kula Gold bursts out gates +60% after hitting visible gold in first Mt Palmer drill hole Smallcap miner Kula Gold has burst out the gates on Friday after reporting "visible gold" in its first diamond drill hole at Mt Palmer.
'Set and forget' vs. DIY super: Which strategy wins? We’ve all been told the same story: Work hard, keep tipping money into your super, and let @time in the market” do the heavy lifting. Supposedly, that’s the ticket to a comfortable retirement. But here’s the uncomfortable truth...

Featured News

NEWS ANSTO continuous piloting confirms exceptional rare earth recoveries
right-arrow Created with Sketch.
NEWS First assay results returned from ongoing drilling at Gold Duke Project
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 025 – Locksley rap video gives Hilltop Hoods run for money
right-arrow Created with Sketch.
NEWS The biggest ASX director trades from the last week
right-arrow Created with Sketch.
NEWS Southern Silver Exploration: Unlocking value at Cerro Las Minitas amid rising metal prices
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.